PRJNA835161
Identification the factors contributed resistance to cisplatin in bladder cancer cells
Chemotherapy is still one of the most important adjuvant treatments for bladder cancer (BC). However, like other malignancies, BC is prone to chemotherapy resistance and only about half of muscle-invasive BC patients responds to cisplatin-based chemotherapy. The aim of this study is to unveil the mechanisms underlying the chemoresistance to cisplatin in BC cells